Deborah Hemingway, a biophysics Ph.D. and founder of Ecphora Capital, is transforming venture capital in Maryland by focusing on early-stage medical technology investments. In just two years, her firm has raised $15 million and supported 11 companies. Hemingway’s diverse background includes launching her first business in high school, working with numerous startups, and conducting biophysics research at the University of Maryland. She aims to fill funding gaps in med tech and help local startups thrive, leveraging Maryland’s renowned research institutions. Committed to innovation and resilience, Hemingway guides founders through challenges to drive impactful solutions.